Cascala Health, an AI platform for care teams and post-acute care providers, has secured $8.6 million in seed financing, bringing its total raise to $11.23 million since its launch in 2024.
Flare Capital Partners and Eniac Ventures led the round, with additional backing from Omega Healthcare Investors, Ziegler Link-age Fund, Tau Ventures and Digital Health Venture Partners.
WHAT IT DOES
Cascala integrates with EMRs, pulling admission discharge transfer feeds, claims, labs and imaging. It also delivers reports into the EMR via direct messaging.
According to the company, the platform keeps providers, teams and systems aligned with next steps and shared visibility across transitions of care.
It also reduces manual burden by automating documentation, communication and follow-up workflows.
Cascala Health said it will use the funds to increase product development, grow its clinical intelligence capabilities and promote growth of its customer service implementation team.
"At Cascala, we see care transitions as one of the most critical yet underserved aspects of the patient journey," Matt Murphy, Cascala Health cofounder and CEO, told MobiHealthNews.
"Every missed handoff gap creates risk for patients and unnecessary burden for clinicians. By bringing clinically responsible AI directly into existing workflows, we are helping organizations not only reduce administrative waste but also deliver safer, more connected care at scale. We are delivering tools that do not just promise efficiency, they deliver measurable results from day one."
MARKET SNAPSHOT
Other companies in this space include athenahealth, which in July announced it migrated all eligible providers on the athenaOne network to the Trusted Exchange Framework and Common Agreement (TEFCA).
The company also said it has been rolling out CharSync, which allows providers to access and interact with data retrieved from TEFCA and other sources.
In May, Olio, a platform that links hospital teams with post-acute providers for care collaboration, scored $11 million in Series B funding in a round led by Fulcrum Equity Partners.
Olio's care coordination platform allows hospitals' care teams, including doctors and administrators, to access patient information after they transition into the post-acute setting.
The platform allows clinicians to set specialty-specific care goals and exchange data between healthcare providers and post-acute care settings.
In March, ModMed announced that Clearlake Capital Group made a significant majority growth investment in the company. Financial terms of the transaction were not disclosed.
In January, ModMed announced that its electronic healthcare platform EMA was granted Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP) certification to the Predictive Decision Support Intervention criterion.
ModMed said that ASTP certification is pertinent to its AI-powered ambient-listening technology, ModMed Scribe, which utilizes AI natively built into EMA.
